Alnylam Pharmaceuticals (ALNY) Advances Diabetes Drug Into Phase 2 Trial

On April 17, 2026, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) provided an update connected its experimental drug, ALN-4324. Currently successful its Phase 2 objective trial, the company’s experimental RNAi therapeutic cause aims astatine treating benignant 2 diabetes. The proceedings involves a triple-blind, placebo-controlled survey that evaluates the interaction of a azygous subcutaneous injection connected insulin sensitivity. Formally initiated successful March 2026, the proceedings reflects Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)’s strategical enlargement from uncommon diseases into the high-demand metabolic market. If the proceedings turns retired to beryllium successful, it volition elevate the company’s presumption arsenic a formidable competitor, connected par with manufacture leaders similar Eli Lilly and Novo Nordisk.

In a abstracted event, connected April 13, 2026, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) saw an accommodation to its terms people from Truist. The steadfast lowered its terms people from $515 to $505 portion maintaining a Buy standing connected the stock. Truist provided the update arsenic portion of its Q1 results preview among Biotech stocks. The steadfast further told investors that absorption anticipates beardown yearly maturation but cautions astir Q1 seasonal weakness owed to payer dynamics and less shipping weeks.

Founded successful 2002, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is simply a biopharmaceutical company. Based successful Massachusetts, the institution develops and commercializes caller therapeutics based connected ribonucleic acerb interference (RNAi).

While we admit the imaginable of ALNY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: MLP Stocks List: 20 Largest MLPs and 10 High Growth Chemical Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.